Replay available

Atento S.A. Ordinary Shares (ATTO) Q1 2022 Earnings Call

Atento S.A. Ordinary Shares (NYSE: ATTO) Q1 2022 earnings conference call, held 2022-05-12. Replay captured from the company's public earnings webcast.

Thu, May 12, 2022 at 8:30 AMendedReplay
Atento S.A. Ordinary Shares (ATTO) Q1 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ryan O'Hagan

Investor, EIP

Carlos Lopez Abadia

Chief Executive Officer

Jose Acevedo

Chief Financial Officer

Hernan Van Wyveren

Investor Relations Director

Vincent Colicchio

Investor, Barrington Research

Replay transcript excerpt

Good morning, and welcome to Attento's first quarter 2022 results conference call. Today's call is being recorded. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your touchtone phone. To withdraw your question, please press star, then two. If you are at your computer, please use the submitted question box on your webcast from your. I would now like to turn the conference over to Mr. Hernan Van Wyveren, Investor Relations Director for Attento. Please go ahead. Thank you, Operator, and welcome everyone to our fiscal first quarter 2022 earnings call to discuss Attento's financial and operating results. Here with us for today's call are Carlos Lopez Abadia, ATENTOS Chief Executive Officer, and Jose Acevedo, Chief Financial Officer. Following a review of ATENTOS financial and operating results, we will open the call for your questions. Please, operator, turn to slide two. Before proceeding, please note that certain comments made on this call will contain financial information that has been prepared under international financial reporting standards. In addition, this call may contain information that constitutes forward-looking statements which are not guarantees of future performance and involve risk and uncertainties. Surgeon results may differ materially from those in the forward-looking statements as a result of various factors. We encourage you to review our publicly available disclosure documents filed with the relevant security regulators. And we invite you to read the complete disclosure included here on the second slide of our earning...

More from Attovia Therapeutics, Inc.